Amyloid precursor protein Thr668 phosphodependent complexes

Detalhes bibliográficos
Autor(a) principal: Reguengo, Sérgio Paulo Soares
Data de Publicação: 2015
Tipo de documento: Dissertação
Idioma: eng
Título da fonte: Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
Texto Completo: http://hdl.handle.net/10773/15470
Resumo: Alzheimer’s disease has as one of its characteristic hallmarks, deposits of a toxic peptide Aβ, known as senile plaques (SP). The toxic peptide is produced via complex intracellular pathways and cleavage of the Alzheimer’s Amyloid Precursor Protein (APP). Several aspects are key to APP processing. Among them, the proteins that bind to APP and form different complexes, which are functionally relevant. Recent studies have shown that the phosphorylation state of APP itself is determinant with respect to the protein complexes formed. Thus the protein’s phosphorylation state ultimately determines its own fate, the rate of Aβ production and the formation of SPs. It is also noteworthy the patients with Swedish mutation produced 10 times more Aβ. The aim of this thesis is to consider the above mentioned factors, which modulate Aβ production in a unified perspective. That is, to consider how protein phosphorylation affects Aβ production, bearing in mind the phosphorylated state of the protein itself and the complexes that are formed. In order to address these questions, several biological tools have to be available. Hence this thesis set out to prepare the APP Swedish mutations (to produce 10 times more Aβ) on a cDNA which also expressed phosphorylation site mutations on APP Thr668. This was achieved and it was possible to demonstrate that the resulting mutations did in fact produce considerably higher levels of the toxic peptide. Preliminary immunocytochemistry studies allowed for assessment of cellular distribution of the mutants and PP1γ in SHSY5Y cells, and more studies are needed to assess the co-localization of the trimeric protein complex between the APP mutants. PP1γ and Fe65. Therefore additional studies could contribute to a better understanding of the way that Aβ production is influenced by protein complexes regulated by APP phosphorylation.
id RCAP_557966a0217c5e0165b926a0014cfd67
oai_identifier_str oai:ria.ua.pt:10773/15470
network_acronym_str RCAP
network_name_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository_id_str 7160
spelling Amyloid precursor protein Thr668 phosphodependent complexesBiomedicina molecularProteína percursora de amilóideDoença de AlzheimerProteínas - FosforilaçãoAlzheimer’s disease has as one of its characteristic hallmarks, deposits of a toxic peptide Aβ, known as senile plaques (SP). The toxic peptide is produced via complex intracellular pathways and cleavage of the Alzheimer’s Amyloid Precursor Protein (APP). Several aspects are key to APP processing. Among them, the proteins that bind to APP and form different complexes, which are functionally relevant. Recent studies have shown that the phosphorylation state of APP itself is determinant with respect to the protein complexes formed. Thus the protein’s phosphorylation state ultimately determines its own fate, the rate of Aβ production and the formation of SPs. It is also noteworthy the patients with Swedish mutation produced 10 times more Aβ. The aim of this thesis is to consider the above mentioned factors, which modulate Aβ production in a unified perspective. That is, to consider how protein phosphorylation affects Aβ production, bearing in mind the phosphorylated state of the protein itself and the complexes that are formed. In order to address these questions, several biological tools have to be available. Hence this thesis set out to prepare the APP Swedish mutations (to produce 10 times more Aβ) on a cDNA which also expressed phosphorylation site mutations on APP Thr668. This was achieved and it was possible to demonstrate that the resulting mutations did in fact produce considerably higher levels of the toxic peptide. Preliminary immunocytochemistry studies allowed for assessment of cellular distribution of the mutants and PP1γ in SHSY5Y cells, and more studies are needed to assess the co-localization of the trimeric protein complex between the APP mutants. PP1γ and Fe65. Therefore additional studies could contribute to a better understanding of the way that Aβ production is influenced by protein complexes regulated by APP phosphorylation.A Doença de Alzheimer tem como uma das suas características principais, os depósitos do péptido tóxico Aβ, conhecidos como placas senis (PS). O péptido tóxico é produzido por complexas vias intracelulares e clivagens da Proteína Precursora Amiloide (PPA). Vários aspetos são importantes para o processamento da PPA. Entre eles, as proteínas que se ligam à PPA e formam diferentes complexes que são funcionalmente relevantes. Estudos recentes demonstraram que o estado de fosforilação da própria PPA é determinante para a formação desses complexos. Portanto, o estado de fosforilação da PPA determina o seu próprio destino, o rácio de produção de Aβ e a formação de placas senis. É também digno de nota que pacientes com mutação Swedish produzem cerca de 10 vezes mais Aβ. O objetivo desta tese é considerar os fatores acima mencionados que modulam a produção de Aβ numa perspetiva única. Ou seja, considerar como a fosforilação da PPA afeta a produção de Aβ, tendo em conta o próprio estado fosforilado da proteína e os complexos proteicos que dai são formados. De modo a responder a essas questões, várias ferramentas biológicas tem que ser disponibilizadas. Consequentemente, esta tese propõem-se a preparar mutações Swedish na PPA (para produzir 10 vezes mais Aβ), a partir de cDNA da PPA que expressa mutações que imitam a fosforilação da Thr668. Este objetivo foi conseguido e foi possível demonstrar que as referidas mutações produziram níveis consideravelmente altos do péptido tóxico. Estudos preliminares de imunocitoquímica permitiram avaliar a distribuição celular dos mutantes produzidos, bem como da PP1γ em células SH-SY5Y, mas mais estudos são necessários para avaliar a co-localização do complexo proteico trimérico entre os mutantes da PPA, PP1γ e Fe65. Assim sendo, estudos adicionais poderão contribuir para um melhor conhecimento da maneira como a produção de Aβ é influenciada por complexos proteicos regulados pela fosforilação da PPA.Universidade de Aveiro2018-07-20T14:00:53Z2015-12-17T00:00:00Z2015-12-172017-12-10T12:00:00Zinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/masterThesisapplication/pdfhttp://hdl.handle.net/10773/15470TID:201593718engReguengo, Sérgio Paulo Soaresinfo:eu-repo/semantics/openAccessreponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãoinstacron:RCAAP2024-02-22T11:28:37Zoai:ria.ua.pt:10773/15470Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireopendoar:71602024-03-20T02:50:51.078457Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãofalse
dc.title.none.fl_str_mv Amyloid precursor protein Thr668 phosphodependent complexes
title Amyloid precursor protein Thr668 phosphodependent complexes
spellingShingle Amyloid precursor protein Thr668 phosphodependent complexes
Reguengo, Sérgio Paulo Soares
Biomedicina molecular
Proteína percursora de amilóide
Doença de Alzheimer
Proteínas - Fosforilação
title_short Amyloid precursor protein Thr668 phosphodependent complexes
title_full Amyloid precursor protein Thr668 phosphodependent complexes
title_fullStr Amyloid precursor protein Thr668 phosphodependent complexes
title_full_unstemmed Amyloid precursor protein Thr668 phosphodependent complexes
title_sort Amyloid precursor protein Thr668 phosphodependent complexes
author Reguengo, Sérgio Paulo Soares
author_facet Reguengo, Sérgio Paulo Soares
author_role author
dc.contributor.author.fl_str_mv Reguengo, Sérgio Paulo Soares
dc.subject.por.fl_str_mv Biomedicina molecular
Proteína percursora de amilóide
Doença de Alzheimer
Proteínas - Fosforilação
topic Biomedicina molecular
Proteína percursora de amilóide
Doença de Alzheimer
Proteínas - Fosforilação
description Alzheimer’s disease has as one of its characteristic hallmarks, deposits of a toxic peptide Aβ, known as senile plaques (SP). The toxic peptide is produced via complex intracellular pathways and cleavage of the Alzheimer’s Amyloid Precursor Protein (APP). Several aspects are key to APP processing. Among them, the proteins that bind to APP and form different complexes, which are functionally relevant. Recent studies have shown that the phosphorylation state of APP itself is determinant with respect to the protein complexes formed. Thus the protein’s phosphorylation state ultimately determines its own fate, the rate of Aβ production and the formation of SPs. It is also noteworthy the patients with Swedish mutation produced 10 times more Aβ. The aim of this thesis is to consider the above mentioned factors, which modulate Aβ production in a unified perspective. That is, to consider how protein phosphorylation affects Aβ production, bearing in mind the phosphorylated state of the protein itself and the complexes that are formed. In order to address these questions, several biological tools have to be available. Hence this thesis set out to prepare the APP Swedish mutations (to produce 10 times more Aβ) on a cDNA which also expressed phosphorylation site mutations on APP Thr668. This was achieved and it was possible to demonstrate that the resulting mutations did in fact produce considerably higher levels of the toxic peptide. Preliminary immunocytochemistry studies allowed for assessment of cellular distribution of the mutants and PP1γ in SHSY5Y cells, and more studies are needed to assess the co-localization of the trimeric protein complex between the APP mutants. PP1γ and Fe65. Therefore additional studies could contribute to a better understanding of the way that Aβ production is influenced by protein complexes regulated by APP phosphorylation.
publishDate 2015
dc.date.none.fl_str_mv 2015-12-17T00:00:00Z
2015-12-17
2017-12-10T12:00:00Z
2018-07-20T14:00:53Z
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/masterThesis
format masterThesis
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://hdl.handle.net/10773/15470
TID:201593718
url http://hdl.handle.net/10773/15470
identifier_str_mv TID:201593718
dc.language.iso.fl_str_mv eng
language eng
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Universidade de Aveiro
publisher.none.fl_str_mv Universidade de Aveiro
dc.source.none.fl_str_mv reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron:RCAAP
instname_str Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron_str RCAAP
institution RCAAP
reponame_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
collection Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository.name.fl_str_mv Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
repository.mail.fl_str_mv
_version_ 1799137558052995072